Navigation Links
Targeted gene silencing drugs are more than 500 times more effective with new delivery method
Date:12/21/2012

New Rochelle, NY, December 20, 2012Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging. An innovative delivery approach that dramatically increases the efficacy of an siRNA drug targeted to the liver and has made it possible to test the drug in non-human primates is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers (http://www.liebertpub.com). The article is available on the Nucleic Acid Therapeutics website (http://www.liebertpub.com/nat).

In the article "Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs In Vivo" (http://online.liebertpub.com/doi/full/10.1089/nat.2012.0389) Wong and colleagues from Arrowhead Madison Inc. (Madison, WI) present a novel strategy to overcome the difficulty in delivering high levels of a gene knockdown siRNA drug to liver cells. While the cholesterol-conjugated siRNA drug is taken up preferentially by the liver, it is encapsulated in membrane-bound globules called endosomes and cannot reach the cells' DNA to exert its gene silencing effect. The researchers co-injected a polymer with the drug that also targets the liver and, once inside liver cells, breaks open the endosomes, releasing the siRNA drug.

"The promise of siRNAs is as strong as ever and is becoming even more so with progress in delivering these molecules to the right place at the right time," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "The work by Wong and colleagues is another important step towards realizing this promise."


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related medicine news :

1. Complexities of human disease targeted with $16 million in funding
2. Targeted micro-bubbles detect artery inflammation, MU study finds
3. Weekly dose reduces targeted drugs side effects, but not its activity against ALL
4. Targeted prostate biopsy has potential to improve diagnosis of prostate cancer
5. Targeted Prostate Cancer Biopsies Might Improve Care: Study
6. Researchers report first success of targeted therapy in most common non-small cell lung cancer
7. New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
8. Temple researchers show targeted cancer drug may stunt hearts ability to repair itself
9. Large lung cancer study shows potential for more targeted therapies
10. Deadly witch hunts targeted by grassroots womens groups
11. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Targeted gene silencing drugs are more than 500 times more effective with new delivery method
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online plastic ... . The forum section was recently revamped and upgraded to allow even more interaction ... use across the country. , According to the senior editor of Cosmetic Town, “We ...
(Date:4/28/2016)... ... ... In many parts of the world, contamination from human waste is a ... in underdeveloped parts of Africa where clean sources of food and water are scarce. ... will examine this global health issue and consider how it compares to other major ...
(Date:4/28/2016)... , ... April 28, 2016 ... ... provider of enterprise Data Center Infrastructure Management solutions, announces today the availability ... feature enhancements in the area of capacity management and optimization, providing new ...
(Date:4/28/2016)... Texas (PRWEB) , ... April 28, 2016 , ... Amada ... opened its newest office in San Antonio – its San Antonio West location. Prior ... years in medical device sales. The grand opening of Amada San Antonio West will ...
(Date:4/28/2016)... ... April 28, 2016 , ... Anzu®, ... announced a new Residency Education & Collaboration Platform for hospitals and medical ... and a host of collaboration tools designed to improve patient outcomes through ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
(Date:4/27/2016)... , April 27, 2016 ... accelerator (MR-linac) platform will be the focal point of ... of the European Society for Radiotherapy & Oncology, taking ... MR-linac integrates a state-of-the-art radiotherapy system and a high-field ... to clearly see the patient,s anatomy in real time. ...
(Date:4/27/2016)... , April 27, 2016 Shire ... Jeff Poulton , Chief Financial Officer, will present at ... Boston, MA on Wednesday, May 04, 2016, ... webcast will be available on the Presentations and Webcasts section ... replay of the webcast will be available on this same ...
Breaking Medicine Technology: